Revolution Medicines director Lorence H. Kim disposes of 17,090 common shares worth USD 3.57 million - RVMD News | RalliesRevolution Medicines director Lorence H. Kim disposes of 17,090 common shares worth USD 3.57 million
R
RVMD• Director disclosure of share sales
- Director Lorence H. Kim disclosed sales of 17,090 Revolution Medicines common shares on Sep. 8, 2026.
- Sales were executed through a trust at weighted average prices of USD 206.6 to USD 212.27.
- The trust’s beneficial ownership fell to zero shares following the transactions.
- Kim reported 1,191 common shares held directly following the filing.
ZSQR
•
